Theme: Ensuring Drug Safety in Healthcare System

Pharmacovigilance Congress 2016

Pharmacovigilance Congress 2016

Conference Series LLC organizing gratifying Pharmaceutical conferences welcomes you to attend the 6th Pharmacovigilance Congress to be held during September 28-30, 2016 in Toronto, Canada focuses on the advancements in pharmacovigilance and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making immense impacts in medical sciences and pharmaceuticals. 6thPharmacovigilance Congress accentuate on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of 6th Pharmacovigilance Congress is “Ensuring Drug Safety in Healthcare System”.

Track-1: Drug Safety:

Drug Safety (Pharmacovigilance) is the Pharmacological science relating to the collection, detection, determination, control, and inhibiting of adverse effects with Pharmaceutical products. In this Track it is discussed about the Drug Safety and its applications in various fields.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques, March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and Bioavailability Congress, June06-08,2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxic genomics, June 09-10,2016, Dallas, USA; 6thInternational Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Antonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance Conference; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM).

Track-2: Adverse Drug Reactions:

An Adverse Drug Reaction (ADR) is a response to drug which is noxious and unintended and which occurs at doses normally used in man for the prophylaxis, analysis, or therapy of disease or for the modification of physiological function. Many Adverse Drug Reactions represent an excess of the drug's therapeutic effects Manufacturers, professionals, and consumers should report Post Marketing Reports on adverse effects. How we reduce the adverse drug reactions is discussed in Reduction of adverse drug reaction by Nanotechnology topic.

Related Conferences:

2nd International Conference on Clinical Trials, on August 22-24, 2016, Philadelphia, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, SanAtonio, USA; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics , June 09-10, 2016, Dallas, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26,2016, Istanbul, Turkey; Asia Pacific Drug Formulation and Bioavailability Congress,  Beijing, China, June 06-08, 2016; 6th Annual Pharmacovigilance and Risk Management Strategies Forum;     Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance Conference; Conference on Pharmacovigilance and Clinical Trials; Conference on Pharmacovigilance and Drug Safety. International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU )

Track 3: Pharmacovigilance Significance &Scope:

Pharmacovigilance and its Significance and Scope present the case for the importance of pharmacovigilance, to record its growth and potential as an important discipline within Medical science, and to describe its impact on patient welfare and public health and to know what is pharmacovigilance. In this track, we discussed about the Significance of pharmacovigilance. We also discussed on Pharmacovigilance role in healthcare system. Worldwide every year so many pharmacovigilance conferences were going on.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques, March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug  Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6thInternational Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey ; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety ; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Group of the European Union (PGEU ), European Association of Employed Community Pharmacists in Europe (EPhEU).

Track 4: Continental Pharmacovigilance:

Continental Pharmacovigilance gives an extension to Ensuring compliance with local and international requirements. To operate more efficaciously across multiple regions and Health authorities.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU).

Track 5: Good Pharmacovigilance Practice:

Pharmacovigilance and Pharmacoepidemiology mainly deal to avoid the insufficient evidence of safety from clinical trials. To maintain the reporting practices avoid major problems in risk management. In addition, it is important to intensify on Signal investigation through observational studies and Interpreting safety signals. The pharmacovigilance Clinical Trials services companies must have the Pharmacovigilance Certification.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU).

Track 6: Pharmacovigilance and Risk Management:

Pharmacovigilance and Risk Management plays major role in Drug industry. The new turn in Drug industry is to use Information technology in pharmacovigilance companies. Drug Industry need to promoting companies in pharmacovigilance practice and the Review of software’s used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in Risk Management. In this conferences so many experts from different Pharmacovigilance CRO’s, Pharmacovigilance service providers were participates and shares their knowledge and discusses about the new updates. In this year, there is an International conference on Pharmacovigilance 2016, which is held in Austria on September 19-21.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU).

 

Track 7: Pharmacokinetics and Pharmacodynamics:

Drugs may undergo, Pharmacokinetics and Pharmacodynamics and Toxicity testing through animal testing. This data allows researchers to allometrically estimate a safe starting dose of the drug for clinical trials in humans. In this track mainly we focused on Advances in pharmacodynamics interactions, Drug and substance abuse, Drug-Drug Interactions. Also discussed about the Pharmacy Practices to maintain the Pharmacokinetics and Pharmacodynamics and its Challenges and its guidelines. There are several Challenges in compounding and dispensing practice in Pharmacokinetics and Pharmacodynamics.

Related Conferences:

Asia Pacific Drug Formulation and Bioavailability Congress , June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics , June 09-10, 2016, Dallas, USA;  2nd International Conference on Clinical Trials , August 22-24, 2016, Philadelphia, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey ;6th Annual Pharmacovigilance and Risk Management Strategies Forum; Conference on Pharmacovigilance and Drug Safety. International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU )

Track 8: Pre-Clinical and Clinical Trials:

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. In Designing of trials, there are pre-clinical studies and different phases of clinical trials. In this trails they estimate the Bioassay and its types. The Data collection and quality control is the major part in Pre-Clinical and Clinical Trials. For some specific drugs, there are some Alternative trials designs and models are used. Pre-Clinical and Clinical Trials are conducted as Multi center trials and monitoring basis. Each Pre-Clinical and Clinical Trials study of a drug, biological product, or medical device regulated by the FDA must be reviewed, approved, and monitored by the Regulatory authorities and ethics committee. There are several types of clinical trials like Clinical Trials on drugs used in respiratory disorders. Advanced Information technology in clinical trials improves the quality of Pre-Clinical and Clinical Trials.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, June 06-08, 2016, Beijing, China; Asia Pacific Drug Formulation & Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring  and Toxicogenomics, June 09-10, 2016, Dallas, USA; Anatomy and Physiology-2016, August 11-13, 2016, Birmingham, UK ; 2nd International Conference and Expo on Drug Discovery & Designing, October 24-26, 2016, Istanbul, Turkey; Outsourcing in Clinical Trials Europe 2016; 5th Annual Clinical Development and Trials Asia Congress; SCT 37th Annual Meeting (2016); Outsourcing in Clinical Trials East Coast 2016; Conference on Pharmacovigilance and Clinical Trials. Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM)

Track 9: Clinical Trials on Various Disorders:

Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics Emerging technology in clinical trials track mainly deals on the clinical trials in long chronic diseases and several disorders. In This track we discussed about the Recent clinical trials on AIDS, Clinical trials on benign and malignant tumours, Clinical trials on cardiovascular diseases, Clinical trials on diabetes, Clinical Trials of monoclonal and polyclonal antibodies, Clinical trials on drugs used in psychological disorders The current research mainly focus on Applications of Biomarkers in clinical trials.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, June 06-08, 2016, Beijing, China; Asia Pacific Drug Formulation & Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; Anatomy and Physiology-2016, August 11-13, 2016, Birmingham, UK; 2nd International Conference and Expo on Drug Discovery & Designing, October 24-26, 2016, Istanbul, Turkey; Outsourcing in Clinical Trials Europe 2016; 5th Annual Clinical Development and Trials Asia Congress; SCT 37th Annual Meeting (2016); Outsourcing in Clinical Trials East Coast 2016; Conference on Pharmacovigilance and Clinical Trials. International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU )

Track 10: Clinical Research and Statistics:

In Clinical Research Statistics plays major role. Depends upon the Statistics the clinical trials go for regulatory submissions. There are several guidelines mainly ICH guidelines for clinical research and its statistics follow for the clinical research. Stastical analysis of past pharmacovigilance and Adverse Drug Reactions reports also consider for the regulatory submission.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 07-09, 2016, Madrid, Spain; International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; International Conference and Exhibition on Medical Writing and Healthcare Communications, April 28-29, 2016, Dubai, UAE; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; International Conference on Precision Medicine, November 03-05, 2016, Baltimore, USA; Conference on Pharmacodynamics, Biomarkers and Personalized Therapy; Conference on Pharmacology and Toxicology Research. Pharmaceutical Group of the European Union (PGEU ), European Association of Employed Community Pharmacists in Europe (EPhEU)

Track 11: Case Report in Clinical Trials:

Case Report in Clinical Trials plays major role in clinical research. In this track we discussed about the several case reports like Cancer case reports, Cardiovascular trials case report, Case studies on sexually transmitted diseases, Case studies on type 1 and type 2 diabetes, Case reports on drugs used in pregnancy and lactation.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 07-09, 2016, Madrid, Spain; International Conference and Exhibition on Advances in HPLC and Chromatography Techniques, March 17-18, 2016, London, UK; International Conference and Exhibition on Medical Writing and Healthcare Communications, April 28-29, 2016, Dubai, UAE; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; International Conference on Precision Medicine, November 03-05, 2016, Baltimore, USA; Conference on Developing Countries and Pharmacological Sciences; Conference on Pharmacology and Toxicology Research. Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU)

Track 12: Biopharmaceutics:

In Clinical Pharmacology and Bio pharmaceutics track we discussed about the Rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and Bioequivalence studies also plays major role in clinical research.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 07-09, 2016, Madrid, Spain; International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; International Conference and Exhibition on Medical Writing and Healthcare Communications, April 28-29, 2016, Dubai, UAE; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; International Conference on Precision Medicine, November 03-05, 2016, Baltimore, USA; Conference on Pharmacodynamics, Biomarkers and Personalized Therapy; Conference on Pharmacology and Toxicology Research. Pharmaceutical Group of the European Union (PGEU ), European Association of Employed Community Pharmacists in Europe (EPhEU)

Track 13: PV Data Base Management:

There is advantage in centralising all safety data, clinical data, analysis and reporting with one provider. Pharmacovigilance Software tool provides comprehensive analysis of adverse events arising from the use of pharmaceutical products (Medicinal Product, Medical Device, Vaccines, Non-Drug Therapy and Veterinary Medicinal Product). The Drug Safety database allows the risk- benefit analysis of medicinal products taking into account new and emerging information, in the context of cumulative information. Pharmacovigilance since beginning has been a compliance driven activity, wherein your regulatory compliance determines company’s Risk Assessment scores. A Drug Safety Database offers scheduling of alerts for expedited cases, follow-up cases and PSUR/PADER reports submission to meet regulatory timeline compliance.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK ; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics , June 09-10, 2016,Dallas,USA; 6thInternational Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA ; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey ; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA   Pharmacovigilance Conference ; Conference on Pharmacovigilance and Drug Safety. Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM)

Track 14: PV Consulting’s and Business opportunity:

Due to the changing resources necessary to fulfil the regulatory requirements, some companies also choose to outsource or out task Regulatory Affairs to external service providers. Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The stringent regulations on safety monitoring and their periodical revision have led to increased Safety Data collection, analysis and regulatory surveillance, and increased costs. Thus, Pharmacovigilance has become a critical phase in clinical development programs.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU).

Track 15: Regulatory affairs:

Regulatory affairs for clinical trials is the major part in the clinical trials approaches. Every clinical trial must be conduct according to the Regulatory affairs guidelines. There are several Regulatory affairs depending upon the countries. Regulatory Affairs departments are growing within companies. Global harmonization in standards has led to consistent approach in regulatory submissions and hence its review.

Related Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques , March 17-18, 2016, London, UK; Asia Pacific Drug Formulation and  Bioavailability Congress, June 06-08, 2016, Beijing, China; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016, Dallas, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR,  September 12-14, 2016, San Atonio, USA; 2nd International Conference and Expo on Drug Discovery and Designing, October 24-26, 2016, Istanbul, Turkey; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; Pharmacovigilance and Risk Management Strategies 2016; EGA Pharmacovigilance  Conference ; Conference on Pharmacovigilance and Drug Safety; Conference on Pharmacovigilance and Clinical Trials. Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP), European Pharmaceutical Union (EPU).

Track 16: Growth strategies in Pharma:

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances. The updates and advances in Pharmacovigilance regulation system are discussed in Advances in changing pharmacovigilance regulation system track.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics and  Novel Drug Delivery Systems  , March 07-09, 2016, Madrid, Spain; International Conferences and Expo on Industrial Pharmacy, April 28-29, 2016, Dubai, UAE;  6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; Conference on Pharmacy and Pharmaceutical Sciences; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; SCT 37th Annual Meeting (2016). Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), International Pharmaceutical Federation (FIP).

Track 17: Pharmacy Practices and its Challenges:

In Pharmacy Practices and its Challenges track mainly focused on Pharmacy practice and its guidelines and Challenges in compounding and dispensing practice. Dosage regimen, Drug Toxicity and drug safety measures place important position in clinical research.

Related Conferences:

8th International Conference and Exhibition on Pharmaceutics and  Novel Drug Delivery Systems  , March 07-09, 2016, Madrid, Spain; International Conferences and Expo on Industrial Pharmacy, April 28-29, 2016, Dubai, UAE; World Drug Delivery Summit, June 30-July 02, 2016, New Orleans, USA; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Atonio, USA; International Conference on Pharma Marketing, November 17-19, 2016, Alicante, Spain; Conference on Pharmacy and Pharmaceutical Sciences; 6th Annual Pharmacovigilance and Risk Management Strategies Forum; SCT 37th Annual Meeting (2016). European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU )

 

 

Conference Series LLC organizing gratifying Pharmaceutical conferences, welcomes you to attend the 6th Pharmacovigilance congress to be held during September 28-30, 2016 in Toronto, Canada focuses on the advancements in pharmacovigilance and risk management.

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 6th Pharmacovigilance congress emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of 6th Pharmacovigilance congress is “Ensuring Drug Safety in Healthcare System”.

Why to attend???

With members from around the world focused on learning about Pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Pharmacovigilance community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Pharmacovigilance are hallmarks of this conference.

Target Audience:

  • Pharmacovigilance Students, Scientists
  • Pharmacovigilance Researchers
  • Pharmacovigilance Faculty
  • Medical Colleges
  • Pharmacovigilance Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies.

Summary: Pharmacovigilance Congress 2016 welcomes presenters, attendees, and Exhibitors from around the globe to Toronto, Canada. We are delight to invite you to all attend the “6th Pharmacovigilance Congress” which is going to be held during September 28-30, 2016 at Toronto, Canada. The committee is organizing an exciting and informative program including plenary lectures, workshops, symposia on various poster presentations, topics and various programs for participants all over the globe. We invite you to join us at the conference, where you will have meaningful experience with scholars from all over the world. All the members of Pharmacovigilance Congress 2016 organizing committee look forward to meet you at Toronto, Canada.

For more details please visit: http://pharmacovigilancecongress.pharmaceuticalconferences.com/

Importance and Scope: Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of various adverse drug effects or any other medicine related problem. The main purpose of pharmacovigilance is to improve patient’s safety. Pharmacovigilance also supports public health programs by providing reliable information for the efficient assessment of the risk-benefit profile of medicines.

Why Toronto, Canada?

Almost all of the generic drugs sold in Canada are made right here in this country. Canada’s generic pharmaceutical industry employs more than 10,500 Canadians in well-paid, highly skilled jobs, and reinvests 15 per cent of sales (or about $450-million each year) in research and development.

Generic drugs are approved for sale by Health Canada, and are identical or bioequivalent to the brand-name version. By the time a generic version is licensed for sale in Canada, the active substances are very well documented and their safety profiles are well established. Unexpected adverse events for these well-known substances are rare. Even so, Canada’s generic pharmaceutical companies take our post-market surveillance efforts and responsibilities very seriously. All pharmaceutical companies in Canada are required to monitor the use and effect of a given medication, and to detect, assess, understand and prevent any adverse reactions or any other medicine-related problems that arise. These activities and the science behind it are known as “pharmacovigilance” in the pharmaceutical industry.

The global pharmacovigilance market is segmented as follows:

Pharmacovigilance Market, by Phases of Drug Development:

  • Preclinical Studies
  • Phase I
  • Phase II
  • Phase III
  • Phase IV or Post Marketing Surveillance

Pharmacovigilance Market, by Type of Methods:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Pharmacovigilance Market, by Type of Service:

  • In-House
  • Contract Outsourcing

 


    fig1

                                         

Conference Highlights:

  • Drug Safety
  • Adverse Drug Reactions
  • Pharmacovigilance Significance &Scope
  • Continental Pharmacovigilance
  • Good Pharmacovigilance Practice
  • Pharmacovigilance and Risk Management
  • Pharmacokinetics and Pharmacodynamics
  • Pre-Clinical and Clinical Trials
  • Clinical Trials on Various Disorders
  • Clinical Research and Statistics
  • Case Report in Clinical Trials
  • Biopharmaceutics
  • PV Data Base Managemaent
  • PV Consultings And Bussiness opportunity
  • Regulatory affairs
  • Growth strategies in Pharma
  • Pharmacy Practices and its Challenges

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)

 


    fig2

 

Pharmacovigilance-2015

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pharmacovigilance-2015 a wonderful event!

OMICS International hosted  Pharmacovigilance-2015 which was scheduled during August 10-12, 2015 at Crowne Plaza London Heathrow, UK with the theme  Reviving Strategies for Safer Therapeutics in Healthcare System”

The conference had several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various leaders from the fields of Pharmacovigilance and Health Care Business, Professors, Pharmacovigilance Companies, Researchers, students and Research Professionals, who made this event a Grand Success.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Concept of Pharmacovigilance and its Significance and Scope
  • Pre-Clinical and Clinical Trials
  • Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics
  • Adverse Drug Reactions
  • Pharmacokinetics and Pharmacodynamics
  • Pharmacovigilance and Risk Management
  • Good Pharmacovigilance Practice and Pharmacoepidemiology
  • Clinical Pharmacology and Biopharmaceutics
  • Case Report in Clinical Trials
  • Pharmacy Practices and its Challenges

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • Greg Koski, Alliance for Clinical Research Excellence and Safety, USA
  • Angela van der Salm, DADA Consultancy B.V., Netherlands
  • Peter Lannon, Lanpharm Consulting T/A Lanpharm Services, UK
  • Kieran O’Donnell, TMC Pharma Services, UK
  • Alistair Coates, Oviya MedSafe, UK

Series of workshops includes expert presentation by Dr. Greg Koski, Co-founder and President of Alliance for Clinical Research Excellence and Safety, USA, on “Tomorrow, today: Systems approaches to enhance pharmacovigilance and risk management”, Angela van der Salm, Director Pharmacovigilance / Managing partner at DADA Consultancy B.V., Netherlands on “The EU-RMP-Planning risk management in a feasible  fashion”, Giovanni Furlan, EU QPPV from Helsinn Birex Pharmaceuticals, Ireland on “Ineffi ciencies in pharmacovigilance: What we can do now and what could be done in the future”, Subodh Bhardwaj, Vice President  of Arable Corporation, USA, on “Vaccine vigilance: Towards strengthening pharmacovigilance”, Pramod Wable, QA Manager from Daiichi Sankyo Development Ltd, UK, on “Lean, six sigma and ISO and their applications in clinical trials/research”, Doaa A Ghareeb, Associate professor from Alexandria University, Egypt, on “Potential molecular mechanism of Berberise vulgaris extract, berberine and berberine chitosan nanoparticles in Alzheimer treatment


Past Reports  Gallery  

Pharmacovigilance-2014

On October 27-29, 2014, OMICS at HICC Hyderabad, India organized its 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials. This conference was OMICS endeavor to strengthen the future of the Pharmacovigilance & Clinical Trials with scientist’s pharmacists, researchers, health care professionals, university professors, industrialists, pharmaceutical associations, editorial board members of OMICS journals, and students.

The Keynote speakers for the conference were: K C Singhal, NIMS, India; Prakash V Diwan, Anurag Group of Institutions, India; John Barber, Dr.Reddy’s  Laboratories Europe, UK; J Vijay Venkatraman, OviyaMedSafe, India; Mrinal Kamali, Lambda Therapeutics, India and Suresh Rayudu Chitturi, Confederation of Indian Industry, India.

The Keynote sessions, invited lectures by honorable guests, and all the other sessions highlighted the current challenges, issues, opportunities, innovations and ideas, in Pharmacovigilance & Clinical Trials research, that was reflected by the theme of the conference “Safer Drugs to Market by Analysing Latest Developments in Pharmacovigilance, Drug Safety and Risk Management."  The theme touched upon various topics like Pharmacovigilance and its Challenges, Role of Clinical Trials, Clinical Trials on Diseases, Adverse Drug Reactions, Pharmacokinetics and Pharmacodynamics, Pharmacy Practices and its Challenges, Risk Management: New Approaching Paradigm for Pharmacovigilance, Clinical Research and Statistics, Strategies for Growth in Pharma Environment, Good Pharmacovigilance Practice and Pharmacoepidemiology, and Case Report in Clinical Trials. This gave a rewarding learning environment to all the attendees.

OMICS “Pharmacovigilance” is known for uplifting the future of pharmacy by encouraging students and fellow researchers to present their work through poster presentations. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the pharmacy research.

OMICS Group wishes to acknowledge all the organizing committee members, chair and co-chair, editorial board members of OMICS group journals, speakers, students, sponsors, exhibitors and media partners in making this event a great success.

Thank you to everyone for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Pharmacovigilance & Clinical Trials. OMICS therefore, is glad to announce its "4th International Conference and Exhibition on Pharmacovigilance & Clinical Trials” which will be held during August 10-12, 2015 inBirmingham, UK.


Past Reports  Gallery  

Pharmacovigilance-2013

The 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials took place in San Antonio on November 18 – 19,  2013. The conference’s prime agenda was: "Monitoring the Challenges in Drugs Safety and Risk Management to Ensure the Safer Drugs to the Market".

The 2013 Annual Conference reflected the development of pharmacovigilance, drug safety and clinical trials from a new to a mature industry, highlighting through various sessions how the science is having an impact on society, and how it can generate even greater impact.

On the first day opening keynote speakers Walter Schwerdtfeger, Federal Institute for Drugs and Medical Devices Germany, and Keith A. Wesnes, Northumbria University UK, described their path towards social impact. Talking from an investee point of view, Walter Schwerdtfeger elaborated Challenges from the new European pharmacovigilance legislation and their implementation by competent authorities.

The other sessions of the day included presentations regarding Pharmacovigilance and its ChallengesRole of Clinical TrialsClinical Trials on Diseases, and Adverse Drug Reactions, with the main conclusions being that it is an emerging field and a lot is yet to be explored, the second day included Pharmacokinetics and PharmacodynamicsPharmacy Practices and its Challenges and Case Report in Clinical Trials, chaired and co-chaired by Jayshree Mishra, and Keith A. Wesnes. The session was followed by a number of speeches that discussed various PV topics, from financial tools and scientific strategies to impact measurement and different target sectors.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 28-30, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations